Home > Boards > US Listed > Medical - Healthcare > Acasti Pharma, Inc (ACST)

still holding... phase 3 study supposed to wrap

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
jammastermike Member Profile
 
Followed By 2
Posts 219
Boards Moderated 0
Alias Born 05/01/18
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/1/2019 9:01:17 AM
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire Inc. - 10/1/2019 9:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/30/2019 8:37:48 AM
Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 i... GlobeNewswire Inc. - 9/30/2019 8:35:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/9/2019 8:42:19 AM
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity GlobeNewswire Inc. - 9/9/2019 8:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/4/2019 9:01:16 AM
Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th GlobeNewswire Inc. - 9/4/2019 9:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/28/2019 4:06:14 PM
Acasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and Equity Incentive Plans and Other Re... GlobeNewswire Inc. - 8/28/2019 4:05:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/14/2019 8:01:16 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/14/2019 8:01:11 AM
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020 GlobeNewswire Inc. - 8/14/2019 8:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/12/2019 6:01:24 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/7/2019 8:01:04 AM
Acasti Pharma Schedules First Quarter Fiscal 2020 Conference Call GlobeNewswire Inc. - 8/7/2019 8:00:00 AM
Securities Registration (foreign Private Issuer) (f-3) Edgar (US Regulatory) - 8/7/2019 6:02:59 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/6/2019 6:05:32 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/1/2019 6:03:48 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/25/2019 3:56:59 PM
Acasti Pharma Comments on Trading Activity and Reaffirms No Plans to Raise Capital GlobeNewswire Inc. - 7/25/2019 3:42:52 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/19/2019 3:06:31 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/18/2019 6:01:01 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 7/15/2019 5:16:42 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/5/2019 9:01:41 AM
jammastermike   Tuesday, 04/02/19 06:42:08 PM
Re: None
Post # of 537 
still holding... phase 3 study supposed to wrap up this month... phase 3 results being published soon... good freaking luck!

lol this board only has 47 followers... can you believe that shite?!

crazy, man... i'm tellin youse!! phreakin crazy! da fuq?!

hello??!!



((( crickets )))


((( coyote howl )))


((( hawk screech and blowing wind )))

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist